Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Q3 2023 Earnings Call Transcript

Page 4 of 4

Scott Gordon: The last question was addressed in the live Q&A. So that concludes our questions submitted. So thank you. Operator, I’ll turn the call back over to Jeff for closing remarks.

Jeff Thompson: Well, great. Thanks. Thanks to everybody for joining. We’ve been doing a lot of hard work. I want to thank all the employees. Everyone’s been doing a great job. This dev team, I now know what they go through. We sat in fields for hours and it would light artillery going off flying drones and freezing our buffs off. So I just want to thank everybody for all the hard work. And I’m kind of just going to restate my summary and my remarks, because we now have a completed new state of the art fact in Salt Lake City. We have tons of chips to build thousands of drones. Our drone is the best in class now getting a great response. We will have some new news with first responders coming over the next few weeks. And Skypersonic is starting to get its legs in the military. So lots of opportunity, lots of exciting things coming your way. And I’m just very excited to be here with you. And thanks for joining the call. That’s all I have.

Operator: The conference has now concluded. Thank you for attending today’s presentation. You may now disconnect.

Follow Rhythm Pharmaceuticals Inc. (NASDAQ:RYTM)

Page 4 of 4